Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review

2024-1-1

Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report

2024-1-1

Erratum to “History repeating: guidelines to address common problems in psychedelic science”

2024-1-1

The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use

2024-1-1

Using in silico methods to determine optimal tapering regimens for decanoate-based long-acting injectable psychosis drugs

2024-1-1

Drug safety in older patients with alcohol use disorder: a retrospective cohort study

2024-1-1

Psychedelic skepticism: back to the sixties?

2024-1-1

Corrigendum to “Managing medical and psychiatric multimorbidity in older patients”

2024-1-1

Sublingual asenapine for agitation in malabsorptive states: three patient cases

2024-1-1

Long-acting antipsychotic treatments: focus on women with schizophrenia

2024-1-1

Corrigendum to ‘Comment on: History repeating: guidelines to address common problems in psychedelic science’

2024-1-1

Attentional bias modification and attention control training in PTSD: a systematic review and meta-analysis

2024-1-1

Efficacy and safety of long-acting injectable <i>versus</i> oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis

2024-1-1

Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression

2024-1-1

Patients’ awareness of recovery mediates the link between clinical and level of functional remission in schizophrenia to a larger extent in those treated with long-acting antipsychotics

2024-1-1

Network analysis of the comorbidity between post-traumatic stress, depression and anxiety symptoms among frontline healthcare workers during the COVID-19 pandemic

2024-1-1

Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis

2024-1-1

Corrigendum to “Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series”

2024-1-1

Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery

2024-1-1

Effect of long-acting antipsychotic treatment on psychiatric hospitalization rate in early psychosis patients: a naturalistic study

2024-1-1

Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder

2024-1-1

Clozapine-induced cholinergic urticaria: a case report

2024-1-1

Outcomes of hyperbolic tapering of antidepressants

2023-1-1

The place of long-acting injectable antipsychotics in the treatment of schizophrenia

2023-1-1

Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study

2023-1-1

Enduring neurological sequelae of benzodiazepine use: an Internet survey

2023-1-1

Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia

2023-1-1

Managing medical and psychiatric multimorbidity in older patients

2023-1-1

Serum cytokine variations among inpatients with major depression, bipolar disorder, and schizophrenia <i>versus</i> healthy controls: a prospective ‘true-to-life’ study

2023-1-1

Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications

2023-1-1

Optimizing treatment for older adults with depression

2023-1-1

Altered whole-brain resting-state functional connectivity and brain network topology in typhoon-related post-traumatic stress disorder

2023-1-1

Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies

2023-1-1

Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review

2023-1-1

High-dose olanzapine in treatment-resistant schizophrenia: a systematic review

2023-1-1

A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults

2023-1-1

Ketamine for bipolar depression: an updated systematic review

2023-1-1

Efficacy of intraoperative subanesthetic dose of ketamine/esketamine in preventing postoperative cognitive dysfunction: a systematic review and meta-analysis

2023-1-1

The past, present and future of anticholinergic drugs

2023-1-1

Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?

2023-1-1

Anticholinergic action is rarely a good thing

2023-1-1

Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review

2023-1-1

Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series

2023-1-1

Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia

2023-1-1

Management of dyslipidaemia in individuals with severe mental illness: a population-based study in the Greater Copenhagen Area

2023-1-1

Olanzapine for the treatment of ICU delirium: a systematic review and meta-analysis

2023-1-1

Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness

2023-1-1

Tardive dyskinesia: understanding current challenges in diagnosis and treatment

2023-1-1

Psychosocial interventions to improve adherence in depressed and anxious older adults prescribed antidepressant pharmacotherapy: a scoping review

2023-1-1

Implementing gradual, hyperbolic tapering of long-acting injectable antipsychotics by prolonging the inter-dose interval: an <i>in silico</i> modelling study

2023-1-1